{"id":"https://openalex.org/W7225312896","doi":"https://doi.org/10.20944/preprints202611.0574.v1","title":"Mirvetuximab Soravtansine Suppresses Hypoxia and Mesenchymal Programs in FR\u03b1-Positive Endometrial Cancer Patient-Derived Xenografts","display_name":"Mirvetuximab Soravtansine Suppresses Hypoxia and Mesenchymal Programs in FR\u03b1-Positive Endometrial Cancer Patient-Derived Xenografts","publication_year":2026,"publication_date":"2026-11-05","ids":{"openalex":"https://openalex.org/W7225312896","doi":"https://doi.org/10.20944/preprints202611.0574.v1"},"language":"en","primary_location":{"id":"doi:10.20944/preprints202611.0574.v1","doi":"https://doi.org/10.20944/preprints202611.0574.v1","is_oa":true,"landing_page_url":"https://doi.org/10.20944/preprints202611.0574.v1","pdf_url":null,"source":{"id":"https://openalex.org/S6309402219","display_name":"Preprints.org","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"},"volume":null,"type":"preprint","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.20944/preprints202611.0574.v1","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111833667","display_name":"Elizabeth E. Hopp","orcid":"https://orcid.org/0000-0002-0577-0501","observed_orcids":["https://orcid.org/0000-0002-0577-0501"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elizabeth E. Hopp","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102098450","display_name":"Zhen Ni Zhou","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zhen Ni Zhou","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159487993","display_name":"Christa Nagel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christa Nagel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160967593","display_name":"Steven Waggoner","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Steven Waggoner","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5160894388","display_name":"Analisa DiFeo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Analisa DiFeo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5160894388"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10668","display_name":"Endometrial and Cervical Cancer Treatments","score":0.8550000190734863,"subfield":{"id":"https://openalex.org/subfields/2729","display_name":"Obstetrics and Gynecology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10668","display_name":"Endometrial and Cervical Cancer Treatments","score":0.8550000190734863,"subfield":{"id":"https://openalex.org/subfields/2729","display_name":"Obstetrics and Gynecology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.013700000010430813,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.008200000040233135,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mirvetuximab-soravtansine","display_name":"mirvetuximab soravtansine","score":1.0},{"id":"https://openalex.org/keywords/endometrial-cancer","display_name":"endometrial cancer","score":0.8519999980926514},{"id":"https://openalex.org/keywords/folate-receptor-alpha","display_name":"folate receptor alpha","score":0.9390000104904175},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.9440000057220459},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.9319999814033508},{"id":"https://openalex.org/keywords/tumor-hypoxia","display_name":"tumor hypoxia","score":0.9620000123977661},{"id":"https://openalex.org/keywords/epithelial-mesenchymal-transition","display_name":"epithelial-mesenchymal transition","score":0.9980000257492065},{"id":"https://openalex.org/keywords/g2-m-checkpoint","display_name":"G2/M checkpoint","score":0.7210000157356262},{"id":"https://openalex.org/keywords/mitotic-arrest","display_name":"mitotic arrest","score":0.8399999737739563},{"id":"https://openalex.org/keywords/glycolysis","display_name":"glycolysis","score":0.6990000009536743},{"id":"https://openalex.org/keywords/interferon-gamma-response","display_name":"interferon-gamma response","score":0.9639999866485596},{"id":"https://openalex.org/keywords/tnf-alpha-nf-kappab-signaling","display_name":"TNF-\u03b1/NF-\u03baB signaling","score":0.8870000243186951},{"id":"https://openalex.org/keywords/il-2-stat5-signaling","display_name":"IL-2/STAT5 signaling","score":0.8960000276565552}],"concepts":[{"id":"https://openalex.org/C2777088508","wikidata":"https://www.wikidata.org/wiki/Q944777","display_name":"Endometrial cancer","level":3,"score":0.7382000088691711},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6133000254631042},{"id":"https://openalex.org/C7836513","wikidata":"https://www.wikidata.org/wiki/Q1641506","display_name":"Hypoxia (environmental)","level":3,"score":0.567300021648407},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5583999752998352},{"id":"https://openalex.org/C162317418","wikidata":"https://www.wikidata.org/wiki/Q252857","display_name":"Transcriptome","level":4,"score":0.48989999294281006},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4569000005722046},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4381999969482422},{"id":"https://openalex.org/C186836561","wikidata":"https://www.wikidata.org/wiki/Q1931516","display_name":"Microarray","level":4,"score":0.3986000120639801},{"id":"https://openalex.org/C18431079","wikidata":"https://www.wikidata.org/wiki/Q1502169","display_name":"Gene expression profiling","level":4,"score":0.38659998774528503},{"id":"https://openalex.org/C31194975","wikidata":"https://www.wikidata.org/wiki/Q20970095","display_name":"HIF1A","level":3,"score":0.33219999074935913},{"id":"https://openalex.org/C2777546739","wikidata":"https://www.wikidata.org/wiki/Q33525","display_name":"Carcinoma","level":2,"score":0.3314000070095062},{"id":"https://openalex.org/C76419328","wikidata":"https://www.wikidata.org/wiki/Q74419","display_name":"Epithelial\u2013mesenchymal transition","level":4,"score":0.32359999418258667},{"id":"https://openalex.org/C8415881","wikidata":"https://www.wikidata.org/wiki/Q6839217","display_name":"Microarray analysis techniques","level":4,"score":0.31839999556541443},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.3122999966144562},{"id":"https://openalex.org/C198826908","wikidata":"https://www.wikidata.org/wiki/Q1922379","display_name":"Mesenchymal stem cell","level":2,"score":0.3118000030517578},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.31119999289512634},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.3077999949455261},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.2969000041484833},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.2833999991416931},{"id":"https://openalex.org/C2779742232","wikidata":"https://www.wikidata.org/wiki/Q839508","display_name":"Endometrium","level":2,"score":0.28040000796318054},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.27730000019073486},{"id":"https://openalex.org/C20251656","wikidata":"https://www.wikidata.org/wiki/Q162643","display_name":"Glycolysis","level":3,"score":0.27399998903274536},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.2703999876976013},{"id":"https://openalex.org/C2779081379","wikidata":"https://www.wikidata.org/wiki/Q7852677","display_name":"Tumor hypoxia","level":3,"score":0.266400009393692},{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.26489999890327454},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.26460000872612},{"id":"https://openalex.org/C2777397205","wikidata":"https://www.wikidata.org/wiki/Q275792","display_name":"Saline","level":2,"score":0.2563000023365021}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.20944/preprints202611.0574.v1","doi":"https://doi.org/10.20944/preprints202611.0574.v1","is_oa":true,"landing_page_url":"https://doi.org/10.20944/preprints202611.0574.v1","pdf_url":null,"source":{"id":"https://openalex.org/S6309402219","display_name":"Preprints.org","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.20944/preprints202611.0574.v1","doi":"https://doi.org/10.20944/preprints202611.0574.v1","is_oa":true,"landing_page_url":"https://doi.org/10.20944/preprints202611.0574.v1","pdf_url":null,"source":{"id":"https://openalex.org/S6309402219","display_name":"Preprints.org","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4312139262","https://openalex.org/W4393988890","https://openalex.org/W2811355495","https://openalex.org/W3168662852","https://openalex.org/W2789756749","https://openalex.org/W4295226725","https://openalex.org/W7224592693","https://openalex.org/W4295817631","https://openalex.org/W3088276265","https://openalex.org/W4392354353"],"abstract_inverted_index":{"Folate":[0],"receptor-\u03b1":[1],"(FR\u03b1)":[2],"is":[3],"overexpressed":[4],"in":[5,26,94,164,197],"a":[6,48,61,66,98],"subset":[7],"of":[8,18,53],"high-grade":[9,35,37],"endometrial":[10,38,198],"cancers,":[11],"but":[12],"the":[13,19],"activity":[14],"and":[15,81,84,97,124,126,132,147,155,158,180],"molecular":[16],"effects":[17],"FR\u03b1-targeting":[20],"antibody\u2013drug":[21],"conjugate":[22],"mirvetuximab":[23],"soravtansine":[24],"(MIRV)":[25],"this":[27],"disease":[28],"are":[29],"undefined.":[30],"Mice":[31],"bearing":[32],"two":[33],"FR\u03b1-positive":[34],"recurrent":[36],"cancer":[39],"patient-derived":[40],"xenografts":[41],"(PDXs;":[42],"UT42,":[43],"UT150)":[44],"were":[45,174],"randomized":[46],"to":[47],"single":[49],"tail":[50],"vein":[51],"injection":[52],"MIRV":[54,89,112,117,140],"(5":[55],"mg/kg)":[56],"or":[57],"phosphate-buffered":[58],"saline":[59],"(control);":[60],"separate":[62],"UT150":[63],"cohort":[64],"received":[65],"second":[67,99],"dose":[68,100],"on":[69],"Day":[70],"9.":[71],"Tumors":[72],"harvested":[73],"24":[74],"hours":[75],"after":[76,111],"treatment":[77],"underwent":[78],"microarray":[79],"profiling":[80],"Hallmark,":[82],"KEGG,":[83],"Gene":[85],"Ontology":[86],"pathway":[87],"scoring.":[88],"significantly":[90],"inhibited":[91],"tumor":[92],"growth":[93],"both":[95,115,165],"models,":[96,116],"produced":[101],"more":[102],"durable":[103],"suppression":[104],"(P<0.03).":[105],"FR\u03b1":[106],"protein":[107],"expression":[108],"was":[109],"maintained":[110],"treatment.":[113],"In":[114],"induced":[118],"E2F":[119],"target":[120],"(z":[121,129,144],"=":[122,130,145,153,168],"8.1":[123],"4.5)":[125],"G2/M":[127],"checkpoint":[128],"4.4":[131],"3.9)":[133],"programs,":[134],"consistent":[135],"with":[136,194],"DM4-induced":[137],"mitotic":[138],"arrest.":[139],"also":[141],"suppressed":[142],"hypoxia":[143,181],"\u22126.4":[146],"\u221211.6),":[148],"epithelial\u2013mesenchymal":[149],"transition":[150],"(EMT;":[151],"z":[152],"\u22124.6":[154],"\u221210.1),":[156],"glycolysis":[157],"interferon-\u03b3":[159],"response":[160],"programs.":[161],"Genes":[162],"reduced":[163],"models":[166],"(n":[167],"117;":[169],"66":[170],"expected":[171],"by":[172],"chance)":[173],"enriched":[175],"for":[176],"TNF\u03b1/NF-\u03baB,":[177],"IL2\u2013STAT5,":[178],"EMT,":[179],"signaling":[182],"(FDR":[183],"\u2264":[184],"0.002).":[185],"These":[186],"exploratory":[187],"findings":[188],"support":[189],"evaluating":[190],"MIRV-based":[191],"combinations,":[192],"including":[193],"anti-angiogenic":[195],"agents,":[196],"cancer.":[199]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2026-11-06T00:00:00"}